The aim of this study was to investigate the feasibility of using serum exosomal microRNAs as novel serological biomarkers for hepatocellular carcinoma (HCC) in patients with chronic …

Sep 18, 2015 · Recent studies have shown that circulating microRNAs are a potential biomarker in various types of malignancies. The aim of this study was to investigate the feasibility of …

Jun 26, 2025 · This study aimed to: (1) establish stepwise animal models for HCC-related conditions including non-alcoholic steatohepatitis (NASH) and fibrosis [8]; (2) identify …

We aimed to establish an optimal biomarker for HCC diagnosis and screening using serum exosomal microRNA or their combination with the traditional marker.

Mar 1, 2019 · To identify specific serum exosomal miRNAs from patients with recurrent HCC after liver transplantation and confirm the value of these miRNAs as novel recurrent biomarkers for …

Recent studies have shown that circulating microRNAs are a potential biomarker in various types of malignancies. The aim of this study was to investigate the feasibility of using serum...

Sep 22, 2015 · Recent studies have shown that circulating microRNAs are a potential biomarker in various types of malignancies. The aim of this study was to investigate the feasibility of …

Herein, serum-derived exosomal microRNA (miRNA) profiling was performed on 80 patients which histologically confirmed HCC and 30 normal controls.

Jun 30, 2014 · This review summarizes the role of exosomal microRNA (miRNA) species as biomarkers in HCC therapy.

May 8, 2021 · In this review, we summarized the expression changes and the functions of exosomal microRNAs in HCC. We also discussed the changes of exosomal …